{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T15:42:50Z","timestamp":1743003770451,"version":"3.40.3"},"publisher-location":"Cham","reference-count":90,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783031054594"},{"type":"electronic","value":"9783031054600"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-3-031-05460-0_5","type":"book-chapter","created":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T14:02:49Z","timestamp":1661608969000},"page":"71-84","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Post-translational Modification in Muscular Dystrophies"],"prefix":"10.1007","author":[{"given":"Martina","family":"Sandon\u00e0","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Saccone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,28]]},"reference":[{"key":"5_CR1","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.1097\/00002060-199509001-00003","volume":"74","author":"CM McDonald","year":"1995","unstructured":"McDonald, C. M., et al. (1995). Profiles of neuromuscular diseases. Duchenne muscular dystrophy. American Journal of Physical Medicine & Rehabilitation, 74, S70\u2013S92.","journal-title":"American Journal of Physical Medicine & Rehabilitation"},{"key":"5_CR2","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0140-6736(02)07815-7","volume":"359","author":"AEH Emery","year":"2002","unstructured":"Emery, A. E. H. (2002). The muscular dystrophies. Lancet (London, England), 359, 687\u2013695.","journal-title":"Lancet (London, England)"},{"key":"5_CR3","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1146\/annurev-genom-083118-014933","volume":"20","author":"CL Himeda","year":"2019","unstructured":"Himeda, C. L., & Jones, P. L. (2019). The genetics and epigenetics of Facioscapulohumeral muscular dystrophy. Annual Review of Genomics and Human Genetics, 20, 265\u2013291.","journal-title":"Annual Review of Genomics and Human Genetics"},{"key":"5_CR4","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.ncl.2013.04.004","volume":"31","author":"PB Shieh","year":"2013","unstructured":"Shieh, P. B. (2013). Muscular dystrophies and other genetic myopathies. Neurologic Clinics, 31, 1009\u20131029.","journal-title":"Neurologic Clinics"},{"key":"5_CR5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ccm.2018.01.004","volume":"39","author":"JC Carter","year":"2018","unstructured":"Carter, J. C., Sheehan, D. W., Prochoroff, A., & Birnkrant, D. J. (2018). Muscular dystrophies. Clinics in Chest Medicine, 39, 377\u2013389.","journal-title":"Clinics in Chest Medicine"},{"key":"5_CR6","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1007\/s13361-019-02139-0","volume":"30","author":"Y Jin","year":"2019","unstructured":"Jin, Y., Diffee, G. M., Colman, R. J., Anderson, R. M., & Ge, Y. (2019). Top-down mass spectrometry of Sarcomeric protein post-translational modifications from non-human primate skeletal muscle. Journal of the American Society for Mass Spectrometry, 30, 2460\u20132469.","journal-title":"Journal of the American Society for Mass Spectrometry"},{"key":"5_CR7","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.2174\/1381612811319230005","volume":"19","author":"VN Uversky","year":"2013","unstructured":"Uversky, V. N. (2013). Intrinsic disorder-based protein interactions and their modulators. Current Pharmaceutical Design, 19, 4191\u20134213.","journal-title":"Current Pharmaceutical Design"},{"key":"5_CR8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/345315a0","volume":"345","author":"JM Ervasti","year":"1990","unstructured":"Ervasti, J. M., Ohlendieck, K., Kahl, S. D., Gaver, M. G., & Campbell, K. P. (1990). Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature, 345, 315\u2013319.","journal-title":"Nature"},{"key":"5_CR9","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/0092-8674(95)90471-9","volume":"82","author":"JE Brenman","year":"1995","unstructured":"Brenman, J. E., Chao, D. S., Xia, H., Aldape, K., & Bredt, D. S. (1995). Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell, 82, 743\u2013752.","journal-title":"Cell"},{"key":"5_CR10","first-page":"243","volume":"14","author":"Z Grozdanovic","year":"1999","unstructured":"Grozdanovic, Z., & Baumgarten, H. G. (1999). Nitric oxide synthase in skeletal muscle fibers: A signaling component of the dystrophin-glycoprotein complex. Histology and Histopathology, 14, 243\u2013256.","journal-title":"Histology and Histopathology"},{"key":"5_CR11","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nature07238","volume":"455","author":"A Nott","year":"2008","unstructured":"Nott, A., Watson, P. M., Robinson, J. D., Crepaldi, L., & Riccio, A. (2008). S-nitrosylation of histone deacetylase 2 induces chromatin remodelling in neurons. Nature, 455, 411\u2013415.","journal-title":"Nature"},{"key":"5_CR12","doi-asserted-by":"publisher","first-page":"19183","DOI":"10.1073\/pnas.0805514105","volume":"105","author":"C Colussi","year":"2008","unstructured":"Colussi, C., et al. (2008). HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment. Proceedings of the National Academy of Sciences of the United States of America, 105, 19183\u201319187.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"5_CR13","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1096\/fj.08-115618","volume":"23","author":"C Colussi","year":"2009","unstructured":"Colussi, C., et al. (2009). Nitric oxide deficiency determines global chromatin changes in Duchenne muscular dystrophy. The FASEB Journal, 23, 2131\u20132141.","journal-title":"The FASEB Journal"},{"key":"5_CR14","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.cell.2015.04.003","volume":"161","author":"CP Garnham","year":"2015","unstructured":"Garnham, C. P., et al. (2015). Multivalent microtubule recognition by tubulin tyrosine ligase-like family Glutamylases. Cell, 161, 1112\u20131123.","journal-title":"Cell"},{"key":"5_CR15","doi-asserted-by":"crossref","unstructured":"Argara\u00f1a, C. E., Barra, H. S., & Caputto, R. (1978). Release of [14C]tyrosine from tubulinyl-[14C]tyrosine by brain extract. Separation of a carboxypeptidase from tubulin-tyrosine ligase. Molecular and Cellular Biochemistry, 19.","DOI":"10.1007\/BF00231230"},{"key":"5_CR16","doi-asserted-by":"publisher","first-page":"8526","DOI":"10.1038\/ncomms9526","volume":"6","author":"JP Kerr","year":"2015","unstructured":"Kerr, J. P., et al. (2015). Detyrosinated microtubules modulate mechanotransduction in heart and skeletal muscle. Nature Communications, 6, 8526.","journal-title":"Nature Communications"},{"key":"5_CR17","doi-asserted-by":"publisher","first-page":"ra56\u2013ra56","DOI":"10.1126\/scisignal.2002829","volume":"5","author":"RJ Khairallah","year":"2012","unstructured":"Khairallah, R. J., et al. (2012). Microtubules underlie dysfunction in Duchenne muscular dystrophy. Science Signaling, 5, ra56\u2013ra56.","journal-title":"Science Signaling"},{"key":"5_CR18","doi-asserted-by":"publisher","unstructured":"Belanto, J. J., et al. (2016). Independent variability of microtubule perturbations associated with dystrophinopathy. Human Molecular Genetics, ddw318. https:\/\/doi.org\/10.1093\/hmg\/ddw318","DOI":"10.1093\/hmg\/ddw318"},{"key":"5_CR19","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1126\/science.1202768","volume":"333","author":"BL Prosser","year":"2011","unstructured":"Prosser, B. L., Ward, C. W., & Lederer, W. J. (2011). X-ROS signaling: Rapid Mechano-chemo transduction in heart. Science, 333, 1440\u20131445.","journal-title":"Science"},{"key":"5_CR20","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/jcsm.12527","volume":"11","author":"D Capitanio","year":"2020","unstructured":"Capitanio, D., et al. (2020). Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: Changes contributing to preserve muscle function in Becker muscular dystrophy patients. Journal of Cachexia, Sarcopenia and Muscle, 11, 547\u2013563.","journal-title":"Journal of Cachexia, Sarcopenia and Muscle"},{"key":"5_CR21","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/0092-8674(84)90273-3","volume":"38","author":"GG Gundersen","year":"1984","unstructured":"Gundersen, G. G., Kalnoski, M. H., & Bulinski, J. C. (1984). Distinct populations of microtubules: Tyrosinated and nontyrosinated alpha tubulin are distributed differently in vivo. Cell, 38, 779\u2013789.","journal-title":"Cell"},{"key":"5_CR22","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1091\/mbc.10.4.1105","volume":"10","author":"G Kreitzer","year":"1999","unstructured":"Kreitzer, G., Liao, G., & Gundersen, G. G. (1999). Detyrosination of tubulin regulates the interaction of intermediate filaments with microtubules in vivo via a kinesin-dependent mechanism. Molecular Biology of the Cell, 10, 1105\u20131118.","journal-title":"Molecular Biology of the Cell"},{"key":"5_CR23","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1089\/ars.2013.5517","volume":"20","author":"CW Ward","year":"2014","unstructured":"Ward, C. W., Prosser, B. L., & Lederer, W. J. (2014). Mechanical stretch-induced activation of ROS\/RNS signaling in striated muscle. Antioxidants & Redox Signaling, 20, 929\u2013936.","journal-title":"Antioxidants & Redox Signaling"},{"key":"5_CR24","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.yjmcc.2012.11.011","volume":"58","author":"BL Prosser","year":"2013","unstructured":"Prosser, B. L., Khairallah, R. J., Ziman, A. P., Ward, C. W., & Lederer, W. J. (2013). X-ROS signaling in the heart and skeletal muscle: Stretch-dependent local ROS regulates [Ca2+]i. Journal of Molecular and Cellular Cardiology, 58, 172\u2013181.","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"5_CR25","doi-asserted-by":"publisher","first-page":"H1653","DOI":"10.1152\/ajpheart.2000.278.5.H1653","volume":"278","author":"DR Webster","year":"2000","unstructured":"Webster, D. R., & Patrick, D. L. (2000). Beating rate of isolated neonatal cardiomyocytes is regulated by the stable microtubule subset. The American Journal of Physiology-Heart and Circulatory Physiology, 278, H1653\u2013H1661.","journal-title":"The American Journal of Physiology-Heart and Circulatory Physiology"},{"key":"5_CR26","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1093\/cvr\/cvm089","volume":"77","author":"C Jung","year":"2008","unstructured":"Jung, C., Martins, A. S., Niggli, E., & Shirokova, N. (2008). Dystrophic cardiomyopathy: Amplification of cellular damage by Ca2+ signalling and reactive oxygen species-generating pathways. Cardiovascular Research, 77, 766\u2013773.","journal-title":"Cardiovascular Research"},{"key":"5_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2006.09.016","volume":"36","author":"N Deconinck","year":"2007","unstructured":"Deconinck, N., & Dan, B. (2007). Pathophysiology of Duchenne muscular dystrophy: Current hypotheses. Pediatric Neurology, 36, 1\u20137.","journal-title":"Pediatric Neurology"},{"key":"5_CR28","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1111\/j.1540-8167.2008.01295.x","volume":"19","author":"JR Erickson","year":"2008","unstructured":"Erickson, J. R., & Anderson, M. E. (2008). CaMKII and its role in cardiac arrhythmia. Journal of Cardiovascular Electrophysiology, 19, 1332\u20131336.","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"5_CR29","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1093\/cvr\/cvs425","volume":"97","author":"S Kyrychenko","year":"2013","unstructured":"Kyrychenko, S., et al. (2013). Hierarchical accumulation of RyR post-translational modifications drives disease progression in dystrophic cardiomyopathy. Cardiovascular Research, 97, 666\u2013675.","journal-title":"Cardiovascular Research"},{"key":"5_CR30","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1073\/pnas.0908540107","volume":"107","author":"J Fauconnier","year":"2010","unstructured":"Fauconnier, J., et al. (2010). Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy. Proceedings of the National Academy of Sciences, 107, 1559\u20131564.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"5_CR31","doi-asserted-by":"publisher","first-page":"19079","DOI":"10.1073\/pnas.1013077107","volume":"107","author":"CM Adamo","year":"2010","unstructured":"Adamo, C. M., et al. (2010). Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy. Proceedings of the National Academy of Sciences, 107, 19079\u201319083.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"5_CR32","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nm.1916","volume":"15","author":"AM Bellinger","year":"2009","unstructured":"Bellinger, A. M., et al. (2009). Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle. Nature Medicine, 15, 325\u2013330.","journal-title":"Nature Medicine"},{"key":"5_CR33","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/S0140-6736(02)11397-3","volume":"360","author":"F Muntoni","year":"2002","unstructured":"Muntoni, F., Brockington, M., Blake, D. J., Torelli, S., & Brown, S. C. (2002). Defective glycosylation in muscular dystrophy. The Lancet, 360, 1419\u20131421.","journal-title":"The Lancet"},{"key":"5_CR34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.tcm.2006.12.002","volume":"17","author":"A Heydemann","year":"2007","unstructured":"Heydemann, A., & McNally, E. M. (2007). Consequences of disrupting the dystrophin-sarcoglycan complex in cardiac and skeletal myopathy. Trends in Cardiovascular Medicine, 17, 55\u201359.","journal-title":"Trends in Cardiovascular Medicine"},{"key":"5_CR35","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1242\/jcs.115.14.2801","volume":"115","author":"J Ehmsen","year":"2002","unstructured":"Ehmsen, J., Poon, E., & Davies, K. (2002). The dystrophin-associated protein complex. Journal of Cell Science, 115, 2801\u20132803.","journal-title":"Journal of Cell Science"},{"key":"5_CR36","doi-asserted-by":"publisher","first-page":"33501","DOI":"10.1074\/jbc.M111.227678","volume":"286","author":"F Sancar","year":"2011","unstructured":"Sancar, F., et al. (2011). The dystrophin-associated protein complex maintains muscle excitability by regulating ca 2+ \u2212dependent K + (BK) channel localization. The Journal of Biological Chemistry, 286, 33501\u201333510.","journal-title":"The Journal of Biological Chemistry"},{"key":"5_CR37","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1016\/j.jacc.2016.02.081","volume":"67","author":"F Kamdar","year":"2016","unstructured":"Kamdar, F., & Garry, D. J. (2016). Dystrophin-deficient cardiomyopathy. Journal of the American College of Cardiology, 67, 2533\u20132546.","journal-title":"Journal of the American College of Cardiology"},{"key":"5_CR38","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.bbamcr.2016.12.020","volume":"1864","author":"M Quattrocelli","year":"2017","unstructured":"Quattrocelli, M., Spencer, M. J., & McNally, E. M. (2017). Outside in: The matrix as a modifier of muscular dystrophy. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1864, 572\u2013579.","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"},{"key":"5_CR39","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1146\/annurev-genom-090314-025003","volume":"16","author":"S Guiraud","year":"2015","unstructured":"Guiraud, S., et al. (2015). The pathogenesis and therapy of muscular dystrophies. Annual Review of Genomics and Human Genetics, 16, 281\u2013308.","journal-title":"Annual Review of Genomics and Human Genetics"},{"key":"5_CR40","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/355696a0","volume":"355","author":"O Ibraghimov-Beskrovnaya","year":"1992","unstructured":"Ibraghimov-Beskrovnaya, O., et al. (1992). Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature, 355, 696\u2013702.","journal-title":"Nature"},{"key":"5_CR41","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s10719-008-9182-0","volume":"26","author":"CJ Moore","year":"2009","unstructured":"Moore, C. J., & Hewitt, J. E. (2009). Dystroglycan glycosylation and muscular dystrophy. Glycoconjugate Journal, 26, 349\u2013357.","journal-title":"Glycoconjugate Journal"},{"key":"5_CR42","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.nmd.2004.11.005","volume":"15","author":"RD Cohn","year":"2005","unstructured":"Cohn, R. D. (2005). Dystroglycan: Important player in skeletal muscle and beyond. Neuromuscular Disorders, 15, 207\u2013217.","journal-title":"Neuromuscular Disorders"},{"key":"5_CR43","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/S0968-0004(00)01731-X","volume":"26","author":"SJ Winder","year":"2001","unstructured":"Winder, S. J. (2001). The complexities of dystroglycan. Trends in Biochemical Sciences, 26, 118\u2013124.","journal-title":"Trends in Biochemical Sciences"},{"key":"5_CR44","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1152\/physrev.00028.2001","volume":"82","author":"DJ Blake","year":"2002","unstructured":"Blake, D. J., Weir, A., Newey, S. E., & Davies, K. E. (2002). Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiological Reviews, 82, 291\u2013329.","journal-title":"Physiological Reviews"},{"key":"5_CR45","doi-asserted-by":"publisher","first-page":"14972","DOI":"10.1016\/S0021-9258(18)82427-9","volume":"268","author":"SH Gee","year":"1993","unstructured":"Gee, S. H., et al. (1993). Laminin-binding protein 120 from brain is closely related to the dystrophin-associated glycoprotein, dystroglycan, and binds with high affinity to the major heparin binding domain of laminin. The Journal of Biological Chemistry, 268, 14972\u201314980.","journal-title":"The Journal of Biological Chemistry"},{"key":"5_CR46","doi-asserted-by":"publisher","first-page":"22315","DOI":"10.1074\/jbc.272.35.22315","volume":"272","author":"JM Ervasti","year":"1997","unstructured":"Ervasti, J. M., Burwell, A. L., & Geissler, A. L. (1997). Tissue-specific heterogeneity in \u03b1-Dystroglycan Sialoglycosylation: Skeletal muscle \u03b1-Dystroglycan is a latent receptor for Vicia villosa agglutinin B 4 masked by sialic acid modification. The Journal of Biological Chemistry, 272, 22315\u201322321.","journal-title":"The Journal of Biological Chemistry"},{"key":"5_CR47","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0014-5793(95)00628-M","volume":"368","author":"A Brancaccio","year":"1995","unstructured":"Brancaccio, A., Schulthess, T., Gesemann, M., & Engel, J. (1995). Electron microscopic evidence for a mucin-like region in chick muscle \u03b1-dystroglycan. FEBS Letters, 368, 139\u2013142.","journal-title":"FEBS Letters"},{"key":"5_CR48","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1432-1033.1997.00166.x","volume":"246","author":"A Brancaccio","year":"1997","unstructured":"Brancaccio, A., Schulthess, T., Gesemann, M., & Engel, J. (1997). The N-terminal region of alpha-Dystroglycan is an autonomous globular domain. European Journal of Biochemistry, 246, 166\u2013172.","journal-title":"European Journal of Biochemistry"},{"key":"5_CR49","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S1534-5807(01)00070-3","volume":"1","author":"A Yoshida","year":"2001","unstructured":"Yoshida, A., et al. (2001). Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Developmental Cell, 1, 717\u2013724.","journal-title":"Developmental Cell"},{"key":"5_CR50","doi-asserted-by":"publisher","first-page":"11279","DOI":"10.1074\/jbc.C900007200","volume":"284","author":"DB-V de Bernab\u00e9","year":"2009","unstructured":"de Bernab\u00e9, D. B.-V., et al. (2009). Loss of alpha-dystroglycan laminin binding in epithelium-derived cancers is caused by silencing of LARGE. The Journal of Biological Chemistry, 284, 11279\u201311284.","journal-title":"The Journal of Biological Chemistry"},{"key":"5_CR51","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nature00837","volume":"418","author":"DE Michele","year":"2002","unstructured":"Michele, D. E., et al. (2002). Post-translational disruption of dystroglycan\u2013ligand interactions in congenital muscular dystrophies. Nature, 418, 417\u2013421.","journal-title":"Nature"},{"key":"5_CR52","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/ng.2252","volume":"44","author":"T Willer","year":"2012","unstructured":"Willer, T., et al. (2012). ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome. Nature Genetics, 44, 575\u2013580.","journal-title":"Nature Genetics"},{"key":"5_CR53","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s10974-013-9362-9","volume":"34","author":"KM Sharpe","year":"2013","unstructured":"Sharpe, K. M., Premsukh, M. D., & Townsend, D. (2013). Alterations of dystrophin-associated glycoproteins in the heart lacking dystrophin or dystrophin and utrophin. Journal of Muscle Research and Cell Motility, 34, 395\u2013405.","journal-title":"Journal of Muscle Research and Cell Motility"},{"key":"5_CR54","doi-asserted-by":"crossref","unstructured":"Chandrasekharan, K. & Martin, P. T. Genetic Defects in Muscular Dystrophy. in Methods in Enzymology vol. 479 291\u2013322 (Elsevier, 2010).","DOI":"10.1016\/S0076-6879(10)79017-0"},{"key":"5_CR55","doi-asserted-by":"publisher","first-page":"C476","DOI":"10.1152\/ajpcell.00456.2008","volume":"296","author":"PT Martin","year":"2009","unstructured":"Martin, P. T., et al. (2009). Overexpression of Galgt2 in skeletal muscle prevents injury resulting from eccentric contractions in both mdx and wild-type mice. American Journal of Physiology-Cell Physiology, 296, C476\u2013C488.","journal-title":"American Journal of Physiology-Cell Physiology"},{"key":"5_CR56","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1212\/WNL.46.5.1354","volume":"46","author":"C Minetti","year":"1996","unstructured":"Minetti, C., Bado, M., Morreale, G., Pedemont, M., & Cordone, G. (1996). Disruption of muscle basal lamina in congenital muscular dystrophy with merosin deficiency. Neurology, 46, 1354\u20131354.","journal-title":"Neurology"},{"key":"5_CR57","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1086\/342975","volume":"71","author":"D Beltr\u00e1n-Valero de Bernab\u00e9","year":"2002","unstructured":"Beltr\u00e1n-Valero de Bernab\u00e9, D., et al. (2002). Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. American Journal of Human Genetics, 71, 1033\u20131043.","journal-title":"American Journal of Human Genetics"},{"key":"5_CR58","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1136\/jmg.2005.031963","volume":"42","author":"J van Reeuwijk","year":"2005","unstructured":"van Reeuwijk, J. (2005). POMT2 mutations cause -dystroglycan hypoglycosylation and Walker-Warburg syndrome. Journal of Medical Genetics, 42, 907\u2013912.","journal-title":"Journal of Medical Genetics"},{"key":"5_CR59","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1073\/pnas.0307228101","volume":"101","author":"H Manya","year":"2004","unstructured":"Manya, H., et al. (2004). Demonstration of mammalian protein O-mannosyltransferase activity: Coexpression of POMT1 and POMT2 required for enzymatic activity. Proceedings of the National Academy of Sciences, 101, 500\u2013505.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"5_CR60","doi-asserted-by":"crossref","unstructured":"Sabatelli, P. et al. Extracellular matrix and nuclear abnormalities in skeletal muscle of a patient with Walker\u2013Warburg syndrome caused by POMT1 mutation. Biochimica et Biophysica Acta - Molecular Basis of Disease 1638, 57\u201362 (2003).","DOI":"10.1016\/S0925-4439(03)00040-1"},{"key":"5_CR61","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0006-291X(03)00924-0","volume":"306","author":"H Manya","year":"2003","unstructured":"Manya, H., et al. (2003). Loss-of-function of an N-acetylglucosaminyltransferase, POMGnT1, in muscle\u2013eye\u2013brain disease. Biochemical and Biophysical Research Communications, 306, 93\u201397.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"5_CR62","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1006\/bbrc.2002.6608","volume":"291","author":"H Kano","year":"2002","unstructured":"Kano, H., et al. (2002). Deficiency of \u03b1-Dystroglycan in muscle\u2013eye\u2013brain disease. Biochemical and Biophysical Research Communications, 291, 1283\u20131286.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"5_CR63","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/28653","volume":"394","author":"K Kobayashi","year":"1998","unstructured":"Kobayashi, K., et al. (1998). An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature, 394, 388\u2013392.","journal-title":"Nature"},{"key":"5_CR64","doi-asserted-by":"publisher","first-page":"R836","DOI":"10.1016\/S0960-9822(00)80039-1","volume":"9","author":"L Aravind","year":"1999","unstructured":"Aravind, L., & Koonin, E. V. (1999). The fukutin protein family \u2013 Predicted enzymes modifying cell-surface molecules. Current Biology, 9, R836\u2013R837.","journal-title":"Current Biology"},{"key":"5_CR65","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1093\/hmg\/10.25.2851","volume":"10","author":"M Brockington","year":"2001","unstructured":"Brockington, M. (2001). Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Human Molecular Genetics, 10, 2851\u20132859.","journal-title":"Human Molecular Genetics"},{"key":"5_CR66","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1086\/324412","volume":"69","author":"M Brockington","year":"2001","unstructured":"Brockington, M., et al. (2001). Mutations in the Fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary Laminin \u03b12 deficiency and abnormal glycosylation of \u03b1-Dystroglycan. American Journal of Human Genetics, 69, 1198\u20131209.","journal-title":"American Journal of Human Genetics"},{"key":"5_CR67","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/glycob\/cws152","volume":"23","author":"K Inamori","year":"2013","unstructured":"Inamori, K., et al. (2013). Xylosyl- and glucuronyltransferase functions of LARGE in \u03b1-dystroglycan modification are conserved in LARGE2. Glycobiology, 23, 295\u2013302.","journal-title":"Glycobiology"},{"key":"5_CR68","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1093\/hmg\/ddg307","volume":"12","author":"C Longman","year":"2003","unstructured":"Longman, C. (2003). Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of -dystroglycan. Human Molecular Genetics, 12, 2853\u20132861.","journal-title":"Human Molecular Genetics"},{"key":"5_CR69","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/88865","volume":"28","author":"PK Grewal","year":"2001","unstructured":"Grewal, P. K., Holzfeind, P. J., Bittner, R. E., & Hewitt, J. E. (2001). Mutant glycosyltransferase and altered glycosylation of \u03b1-dystroglycan in the myodystrophy mouse. Nature Genetics, 28, 151\u2013154.","journal-title":"Nature Genetics"},{"key":"5_CR70","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/mus.20146","volume":"30","author":"PW Reed","year":"2004","unstructured":"Reed, P. W., Mathews, K. D., Mills, K. A., & Bloch, R. J. (2004). The sarcolemma in the Large(myd) mouse. Muscle & Nerve, 30, 585\u2013595.","journal-title":"Muscle & Nerve"},{"key":"5_CR71","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/nature12605","volume":"503","author":"MM Goddeeris","year":"2013","unstructured":"Goddeeris, M. M., et al. (2013). LARGE glycans on dystroglycan function as a tunable matrix scaffold to prevent dystrophy. Nature, 503, 136\u2013140.","journal-title":"Nature"},{"key":"5_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019080","volume":"6","author":"Z Zhang","year":"2011","unstructured":"Zhang, Z., Zhang, P., & Hu, H. (2011). LARGE expression augments the glycosylation of glycoproteins in addition to \u03b1-Dystroglycan conferring Laminin binding. PLoS One, 6, e19080.","journal-title":"PLoS One"},{"key":"5_CR73","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/ng.2253","volume":"44","author":"T Roscioli","year":"2012","unstructured":"Roscioli, T., et al. (2012). Mutations in ISPD cause Walker-Warburg syndrome and defective glycosylation of \u03b1-dystroglycan. Nature Genetics, 44, 581\u2013585.","journal-title":"Nature Genetics"},{"key":"5_CR74","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/brain\/aws312","volume":"136","author":"S Cirak","year":"2013","unstructured":"Cirak, S., et al. (2013). ISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies. Brain: A Journal of Neurology, 136, 269\u2013281.","journal-title":"Brain: A Journal of Neurology"},{"key":"5_CR75","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1016\/j.celrep.2016.02.017","volume":"14","author":"M Kanagawa","year":"2016","unstructured":"Kanagawa, M., et al. (2016). Identification of a post-translational modification with Ribitol-phosphate and its defect in muscular dystrophy. Cell Reports, 14, 2209\u20132223.","journal-title":"Cell Reports"},{"key":"5_CR76","doi-asserted-by":"publisher","first-page":"5616","DOI":"10.1073\/pnas.082613599","volume":"99","author":"HH Nguyen","year":"2002","unstructured":"Nguyen, H. H., Jayasinha, V., Xia, B., Hoyte, K., & Martin, P. T. (2002). Overexpression of the cytotoxic T cell GalNAc transferase in skeletal muscle inhibits muscular dystrophy in mdx mice. Proceedings of the National Academy of Sciences, 99, 5616\u20135621.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"5_CR77","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2353\/ajpath.2007.060927","volume":"171","author":"R Xu","year":"2007","unstructured":"Xu, R., Chandrasekharan, K., Yoon, J. H., Camboni, M., & Martin, P. T. (2007). Overexpression of the cytotoxic T cell (CT) carbohydrate inhibits muscular dystrophy in the dyW mouse model of congenital muscular dystrophy 1A. The American Journal of Pathology, 171, 181\u2013199.","journal-title":"The American Journal of Pathology"},{"key":"5_CR78","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1073\/pnas.0608277104","volume":"104","author":"S Brunelli","year":"2007","unstructured":"Brunelli, S., et al. (2007). Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy. Proceedings of the National Academy of Sciences of the United States of America, 104, 264\u2013269.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"5_CR79","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1083\/jcb.2005070832003r","volume":"200","author":"A Pisconti","year":"2013","unstructured":"Pisconti, A., et al. (2013). Follistatin induction by nitric oxide through cyclic GMP: A tightly regulated signaling pathway that controls myoblast fusion. The Journal of Cell Biology, 200, 359\u2013359.","journal-title":"The Journal of Cell Biology"},{"key":"5_CR80","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/nm1479","volume":"12","author":"GC Minetti","year":"2006","unstructured":"Minetti, G. C., et al. (2006). Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors. Nature Medicine, 12, 1147\u20131150.","journal-title":"Nature Medicine"},{"key":"5_CR81","first-page":"79","volume":"19","author":"S Consalvi","year":"2013","unstructured":"Consalvi, S., et al. (2013). Preclinical studies in the mdx mouse model of duchenne muscular dystrophy with the histone deacetylase inhibitor givinostat. Molecular Medicine (Cambridge, Mass.), 19, 79\u201387.","journal-title":"Molecular Medicine (Cambridge, Mass.)"},{"key":"5_CR82","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/emmm.201202096","volume":"5","author":"C Mozzetta","year":"2013","unstructured":"Mozzetta, C., et al. (2013). Fibroadipogenic progenitors mediate the ability of HDAC inhibitors to promote regeneration in dystrophic muscles of young, but not old mdx mice. EMBO Molecular Medicine, 5, 626\u2013639.","journal-title":"EMBO Molecular Medicine"},{"key":"5_CR83","doi-asserted-by":"publisher","first-page":"547","DOI":"10.2217\/epi.14.36","volume":"6","author":"S Consalvi","year":"2014","unstructured":"Consalvi, S., Saccone, V., & Mozzetta, C. (2014). Histone deacetylase inhibitors: A potential epigenetic treatment for Duchenne muscular dystrophy. Epigenomics, 6, 547\u2013560.","journal-title":"Epigenomics"},{"key":"5_CR84","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1517\/21678707.2016.1130617","volume":"4","author":"M Sandon\u00e1","year":"2016","unstructured":"Sandon\u00e1, M., Consalvi, S., Tucciarone, L., Puri, P. L., & Saccone, V. (2016). HDAC inhibitors for muscular dystrophies: Progress and prospects. Expert Opinion on Orphan Drugs, 4, 125\u2013127.","journal-title":"Expert Opinion on Orphan Drugs"},{"key":"5_CR85","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1101\/gad.234468.113","volume":"28","author":"V Saccone","year":"2014","unstructured":"Saccone, V., et al. (2014). HDAC-regulated myomiRs control BAF60 variant exchange and direct the functional phenotype of fibro-adipogenic progenitors in dystrophic muscles. Genes & Development, 28, 841\u2013857.","journal-title":"Genes & Development"},{"key":"5_CR86","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202050863","volume":"21","author":"M Sandon\u00e0","year":"2020","unstructured":"Sandon\u00e0, M., et al. (2020). HDAC inhibitors tune miRNAs in extracellular vesicles of dystrophic muscle-resident mesenchymal cells. EMBO Reports, 21, e50863.","journal-title":"EMBO Reports"},{"key":"5_CR87","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.nmd.2016.07.002","volume":"26","author":"P Bettica","year":"2016","unstructured":"Bettica, P., et al. (2016). Histological effects of givinostat in boys with Duchenne muscular dystrophy. Neuromuscular Disorders NMD, 26, 643\u2013649.","journal-title":"Neuromuscular Disorders NMD"},{"key":"5_CR88","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1097\/NEN.0b013e318187a832","volume":"67","author":"J Zhang","year":"2008","unstructured":"Zhang, J., Keene, C. D., Pan, C., Montine, K. S., & Montine, T. J. (2008). Proteomics of human neurodegenerative diseases. Journal of Neuropathology and Experimental Neurology, 67, 923\u2013932.","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"5_CR89","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1586\/14789450.4.2.227","volume":"4","author":"S Lovestone","year":"2007","unstructured":"Lovestone, S., et al. (2007). Proteomics of Alzheimer\u2019s disease: Understanding mechanisms and seeking biomarkers. Expert Review of Proteomics, 4, 227\u2013238.","journal-title":"Expert Review of Proteomics"},{"key":"5_CR90","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s00702-006-0512-8","volume":"113","author":"T Schulenborg","year":"2006","unstructured":"Schulenborg, T., et al. (2006). Proteomics in neurodegeneration \u2013 Disease driven approaches. Journal of Neural Transmission, 113, 1055\u20131073.","journal-title":"Journal of Neural Transmission"}],"container-title":["Advances in Experimental Medicine and Biology","Understanding PTMs in Neurodegenerative Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-05460-0_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T14:03:20Z","timestamp":1661609000000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-05460-0_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9783031054594","9783031054600"],"references-count":90,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-05460-0_5","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"28 August 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}